首页/数据集/Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)

Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)

NIAID Data Ecosystem2026-03-10 收录

结直肠癌靶向治疗

临床试验

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2288489 数据链接链接失效反馈

官方服务：

资源简介：

This clinical trial aims to evaluate the efficacy, safety of FOLFIRI with vemurafenib and cetuximab in Advanced Colorectal Cancer Patients with BRAF V600E mutation.

应用场景：

创建时间：

2018-10-15

临床试验

报告质量

OBJECTIVES: To be useable in clinical practice, treatments studied in trials must provide sufficient information to enable clinicians and researchers to replicate. We sought to assess the completeness

DataONE2012-10-31 更新90

FDA_table_with_sens

临床试验

药品监管

This is the final dataset after cross referencing the trials. An explanation of the variables is included in the supplementary file "2011-10-31 Prayle Hurley Smyth Supplementary file 3 variables in th

DataONE2012-01-04 更新90

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

盘尾丝虫病

临床试验

Data collected from participants at during a clinical trial in Hohoe, Ghana where participants are identified by a unique participant ID. There are two datasets. The Safety dataset includes demograph

DataCite Commons2025-02-12 更新80

Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study

甲状腺疾病

临床试验

ABSTRACT Objective To compare the effects of a unique fixed combination levothyroxine/liothyronine (LT4/LT3) therapy in patients with primary hypothyroidism. Subjects and methods This is a randomized,

DataCite Commons2021-03-27 更新90

High-viscosity glass-ionomer vs. composite resin restorations in persons with disability: Five-year follow-up of clinical trial

口腔护理

临床试验

Abstract The aim of this clinical trial was to compare the 5-year cumulative survival of atraumatic restorative treatment restorations using high-viscosity glass-ionomer restorations (ART/HVGIC) and c

Mendeley Data2024-06-25 更新80

Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)

资源简介：

相关数据集